Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
Abstract
A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.
- Inventors:
- Issue Date:
- Research Org.:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1150642
- Patent Number(s):
- 8809291
- Application Number:
- 13/252,148
- Assignee:
- California Pacific Medical Center Research Institute (San Francisco, CA); The Regents of the University of California (Oakland, CA)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
- DOE Contract Number:
- AC03-765F00098
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES
Citation Formats
Desprez, Pierre-Yves, and Campisi, Judith. Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma. United States: N. p., 2014.
Web.
Desprez, Pierre-Yves, & Campisi, Judith. Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma. United States.
Desprez, Pierre-Yves, and Campisi, Judith. Tue .
"Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma". United States. https://www.osti.gov/servlets/purl/1150642.
@article{osti_1150642,
title = {Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma},
author = {Desprez, Pierre-Yves and Campisi, Judith},
abstractNote = {A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2014},
month = {8}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Antisense modulation of inhibitor of DNA binding-1 expression
patent, April 2002
- Baker, Brenda F.; Bennett, C. Frank; Wyatt, Jacqueline
- US Patent Document 6,372,433
The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer
journal, December 2000
- Kebebew, Electron; Treseler, Patrick A.; Duh, Quan-Yang
- Surgery, Vol. 128, Issue 6
Id-1 and Id-2 Are Overexpressed in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis
journal, September 1999
- Maruyama, Haruhisa; Kleeff, Jörg; Wildi, Stefan
- The American Journal of Pathology, Vol. 155, Issue 3, p. 815-822
A Novel Pathway for Mammary Epithelial Cell Invasion Induced by the Helix-Loop-Helix Protein Id-1
journal, August 1998
- Desprez, Pierre-Yves; Lin, Claudia Qiao; Thomasset, Nicole
- Molecular and Cellular Biology, Vol. 18, Issue 8